SARCOPENIC OBESITY
Clinical trials for SARCOPENIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new SARCOPENIC OBESITY trials appear
Sign up with your email to follow new studies for SARCOPENIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy fights frailty in obese older veterans
Disease control CompletedThis study tested whether combining a healthy diet, exercise, and the diabetes drug metformin can reverse frailty and obesity in older veterans aged 65-85. 114 participants were enrolled. The goal was to improve physical function and strength, not to cure the underlying condition…
Matched conditions: SARCOPENIC OBESITY
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Vitamin d boost may help seniors with obesity fight muscle loss
Symptom relief CompletedThis study looked at whether taking a daily high dose of vitamin D3 (10,000 IU) for 12 weeks could improve muscle strength and muscle mass in older adults (60+) with obesity. 29 participants from southern Mexico completed the trial. Researchers measured handgrip strength, muscle …
Matched conditions: SARCOPENIC OBESITY
Phase: NA • Sponsor: Universidad Autónoma Benito Juárez de Oaxaca • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC
-
Body scan breakthrough could help predict COPD complications in seniors
Knowledge-focused CompletedThis study looked at 200 older adults with COPD and a condition called sarcopenic obesity (muscle loss with excess fat). Researchers used a special body scan to measure body composition and see if it could help predict breathing problems, hospital stays, and quality of life. The …
Matched conditions: SARCOPENIC OBESITY
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated May 26, 2026 03:56 UTC
-
Obesity drug WEGOVY under the microscope: who loses the most weight?
Knowledge-focused CompletedThis study followed 1,100 adults with severe obesity who were taking the weight-loss drug WEGOVY. Researchers tracked weight changes over 12 months and looked for patterns in who responded best. They also used artificial intelligence to find which factors—like eating habits or bl…
Matched conditions: SARCOPENIC OBESITY
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC